Shillong, August 13: In a remarkable stride forward, British researchers have made significant progress towards discovering a potential cure for a specific type of childhood kidney disease.
As per IANS, the University of Bristol’s research team showcased a breakthrough gene therapy approach that holds the promise to treat steroid-resistant nephrotic syndrome, a condition affecting kidney health in young patients.
Published in the journal Science Translational Medicine, their study indicated that a single dose of gene therapy, targeting kidney cells, could hold the key to curing this ailment. The researchers identified a crucial faulty gene responsible for encoding the podocin protein, essential for the proper functioning of podocytes within the kidney’s filtration system.
Nephrotic syndrome entails damage to the kidney’s filtration units, resulting in excessive leakage of protein into the urine, leading to swelling, infections, blood clots, and kidney damage. While steroids often manage symptoms, around 10% of pediatric cases do not respond, increasing the risk of kidney failure necessitating dialysis or transplant within a few years.
The researchers believe that early intervention through gene therapy could revolutionize treatment. Professor Moin Saleem, from the Bristol Medical School, explained, “We are hoping that this treatment could be curative. You keep the same podocytes for life, so if we can change their gene expression right at the beginning of the disease, we should be able to prevent this disease from progressing.”
This groundbreaking discovery offers renewed hope to hundreds of children grappling with nephrotic syndrome. Successful implementation of gene therapy would spare patients from the distress of kidney failure and subsequent dialysis or transplant procedures.
The research team employed adeno-associated virus (AAV), a non-disease-causing virus adept at delivering genetic information directly into cells, to target and restore the podocin gene within the correct cell type. This approach is crucial for ensuring sustained and effective treatment.
While challenges remain, this development brings us closer to a potential cure for steroid-resistant nephrotic syndrome, offering an optimistic prospect of transforming the lives of affected children and their families.
